RxDoctor Payments Data

Venkata Kakarlapudi, MD

Otolaryngology · New Albany, INNPI 1851346845

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $23,388 of the $32,588 with a category attached, or 71.8%. 28 manufacturers reported payments, led by Aerin Medical Inc. at 58.6% of the total. Reporting peaked in 2019 at $13,333 and has fallen 93.7% since, to $842 in 2025. Among otolaryngology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,588in general payments, 2019–2025

Across 167 payments — averaging $195.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$19K
  • Acclarent, Inc$7K
  • Medical Device Business Services, Inc.$2K
  • Medtronic$953
  • Optinose US, Inc.$660
  • Regeneron Healthcare Solutions, Inc.$627
  • plus $3K from 22 others
$165,926in research payments, 2019–2025

Across 30 payments — averaging $5530.88 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Aerin Medical Inc.$142K
  • Neurent Medical Limited$24K

What the payments were for

  • Consulting fees$23,38872%
  • Travel & lodging$3,51611%
  • Food & beverage$5,63117%
  • Education$540%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,588 in reported general payments places this provider in the 95th percentile of 193 otolaryngology providers in Indiana.

See all otolaryngology providers in Indiana

Medicare billing

Part B allowed, 2024
$396,577
Medicare patients
861
Services billed
8,518

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl263$6,054
Pantoprazole Sodium253$1,746
Famotidine213$1,656
Epinephrine13$1,178
Fluticasone Propionate68$968
Ofloxacin20$839
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav42$380
Montelukast Sodium72$330
Omeprazole26$247
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen83$171
Methylprednisolone37$157
Mupirocin37$143
Levocetirizine Dihydrochloride26$129
Diazepam39$27

Paid to pharmacies, not to this prescriber.

Other otolaryngology in New Albany

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →